| Epidemiological characteristics of COVID-19 cases and estimates of the reproductive numbers 1 month into the epidemic, Italy, 28 January to 31 March 2020 F Riccardo, M Ajelli, XD Andrianou, A Bella, M Del Manso, M Fabiani, ... Eurosurveillance 25 (49), 2000790, 2020 | 292 | 2020 |
| COVID-19 disease severity risk factors for pediatric patients in Italy S Bellino, O Punzo, MC Rota, M Del Manso, AM Urdiales, X Andrianou, ... Pediatrics 146 (4), 2020 | 254 | 2020 |
| Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART B Ensoli, S Bellino, A Tripiciano, O Longo, V Francavilla, S Marcotullio, ... PloS one 5 (11), e13540, 2010 | 123 | 2010 |
| The impact of immunization programs on 10 vaccine preventable diseases in Italy: 1900–2015 P Pezzotti, S Bellino, F Prestinaci, S Iacchini, F Lucaroni, L Camoni, ... Vaccine 36 (11), 1435-1443, 2018 | 101 | 2018 |
| HLA and AB0 polymorphisms may influence SARS-CoV-2 infection and COVID-19 severity A Amoroso, P Magistroni, F Vespasiano, A Bella, S Bellino, F Puoti, ... Transplantation 105 (1), 193-200, 2021 | 99 | 2021 |
| Clinical and psychosocial correlates of post‐herpetic neuralgia A Volpi, A Gatti, F Pica, S Bellino, LT Marsella, AF Sabato Journal of medical virology 80 (9), 1646-1652, 2008 | 89 | 2008 |
| Characteristics of COVID-19 patients dying in Italy: report based on available data on March 20th, 2020 COVID-19 Surveillance Group Rome, Italy: Instituto Superiore Di Sanita, 2020 | 88 | 2020 |
| Impact of a nationwide lockdown on SARS-CoV-2 transmissibility, Italy G Guzzetta, F Riccardo, V Marziano, P Poletti, F Trentini, A Bella, ... Emerging infectious diseases 27 (1), 267, 2021 | 82 | 2021 |
| The impact of a nation-wide lockdown on COVID-19 transmissibility in Italy G Guzzetta, F Riccardo, V Marziano, P Poletti, F Trentini, A Bella, ... arXiv preprint arXiv:2004.12338, 2020 | 76 | 2020 |
| Phase I therapeutic trial of the HIV-1 Tat protein and long term follow-up O Longo, A Tripiciano, V Fiorelli, S Bellino, A Scoglio, B Collacchi, ... Vaccine 27 (25-26), 3306-3312, 2009 | 76 | 2009 |
| HIV-1 Tat addresses dendritic cells to induce a predominant Th1-type adaptive immune response that appears prevalent in the asymptomatic stage of infection E Fanales-Belasio, S Moretti, V Fiorelli, A Tripiciano, MR Pavone Cossut, ... The Journal of Immunology 182 (5), 2888-2897, 2009 | 71 | 2009 |
| The preventive phase I trial with the HIV-1 Tat-based vaccine B Ensoli, V Fiorelli, F Ensoli, A Lazzarin, R Visintini, P Narciso, A Di Carlo, ... Vaccine 28 (2), 371-378, 2009 | 69 | 2009 |
| Epidemiological characteristics of COVID-19 cases in non-Italian nationals notified to the Italian surveillance system M Fabiani, A Mateo-Urdiales, X Andrianou, A Bella, M Del Manso, ... European journal of public health 31 (1), 37-44, 2021 | 67 | 2021 |
| HIV-1 tat promotes integrin-mediated HIV transmission to dendritic cells by binding Env spikes and competes neutralization by anti-HIV antibodies P Monini, A Cafaro, IK Srivastava, S Moretti, VA Sharma, C Andreini, ... PLoS One 7 (11), e48781, 2012 | 65 | 2012 |
| HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial F Ensoli, A Cafaro, A Casabianca, A Tripiciano, S Bellino, O Longo, ... Retrovirology 12, 1-28, 2015 | 63 | 2015 |
| Human immunodeficiency virus protease inhibitors reduce the growth of human tumors via a proteasome‐independent block of angiogenesis and matrix … E Toschi, C Sgadari, L Malavasi, I Bacigalupo, C Chiozzini, D Carlei, ... International journal of cancer 128 (1), 82-93, 2011 | 57 | 2011 |
| The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+T-cell decay and viral load, and with delay of disease … S Bellino, A Tripiciano, O Picconi, V Francavilla, O Longo, C Sgadari, ... Retrovirology 11, 1-8, 2014 | 52 | 2014 |
| HIV-1 Tat-based vaccines: an overview and perspectives in the field of HIV/AIDS vaccine development A Caputo, R Gavioli, S Bellino, O Longo, A Tripiciano, V Francavilla, ... International reviews of immunology 28 (5), 285-334, 2009 | 51 | 2009 |
| Ritonavir or saquinavir impairs the invasion of cervical intraepithelial neoplasia cells via a reduction of MMP expression and activity G Barillari, A Iovane, I Bacigalupo, C Palladino, S Bellino, P Leone, ... Aids 26 (8), 909-919, 2012 | 49 | 2012 |
| Parallel conduction of the phase I preventive and therapeutic trials based on the Tat vaccine candidate S Bellino, V Francavilla, O Longo, A Tripiciano, G Paniccia, A Arancio, ... Reviews on Recent Clinical Trials 4 (3), 195-204, 2009 | 49 | 2009 |
